Camacho, M, Vazquez-López, C, Valero, C, Holgado, A, Terra, X, Avilés-Jurado, FX, León, X. Transcriptional expression of SLC16A7 as a biomarker of occult lymph node metastases in patients with head and neck squamous cell carcinoma. EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY. 2024; 281(12)DOI:10.1007/s00405-024-08882-9. PMID:39215860. IF:2.200(Q1/3D).

Canduela, PDD, Jurado, FXA, Beltrán, JD, Ruiz, CM, Gadea, AS, López, F. The current situation of tutoring in specialised training in otorhinolaryngology-head and neck surgery in Spain. Where are we? Where do we want to go?. Acta Otorrinolaringologica Espanola. 2024; 75(6)DOI:10.1016/j.otorri.2024.03.002. PMID:. IF:(Q/D).

Ballús, DP, López, L, Bagué, S, Gonzalez, A, Holgado, A, Gras, JR, Szafranska, J. HPV-associated multiphenotypic sinonasal carcinoma. Tumour with indolent behaviour? A case-control study. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).

Vilaró, LL, Prat, A, Piñol, D, Catasús, L, Rosell, SB, Casasayas, M, Cabrerizo, JRG, Szafranska, J. Sinonasal hamarthomas: a rare entity with a challenging diagnosis - how an accurate diagnosis impacts clinical and therapeutic management. VIRCHOWS ARCHIV. 2024; 485DOI:. PMID:. IF:3.100(Q2/3D).

Casasayas, M, Massegur-Solench, H, Martel-Marín, M, Kolanczak, KA, Holgado, A, Gras-Cabrerizo, JR. Lacrimal duct Surgery: Different Techniques and Long-Term Postoperative Results. Indian Journal of Otolaryngology and Head & Neck Surgery. 2024; DOI:10.1007/s12070-024-04670-3. PMID:39376430. IF:0.054(Q4/10D).

Ramírez-Ruiz, RD, Quintillá, M, Sandoval, M, León, L, Costa, JM, Quer, M. Current opinion on laryngeal electromyography. Acta Otorrinolaringologica Espanola. 2024; 75(3)DOI:10.1016/j.otorri.2023.07.001. PMID:37913988. IF:(Q/D).

Valero, C, León, X, Quer, M. Host-related indexes in head and neck cancer. Current Opinion in Otolaryngology & Head and Neck Surgery. 2024; 32(2)DOI:10.1097/MOO.0000000000000954. PMID:38116851. IF:2.000(Q2/3D).

Sansa, A, Valero, C, Pujol, A, Sauter, B, Gayà, J, Quer, M, León, X. Prognostic capacity of PIV (pan-immune-inflammation value) in patients with head and neck squamous cell carcinoma. Acta Otorrinolaringologica Espanola. 2024; 75(2)DOI:10.1016/j.otorri.2023.07.005. PMID:38220048. IF:(Q/D).

Gras-Cabrerizo, JR, Martel-Martin, M, Casasayas-Plass, M, Kolanczak, K, Lopez-Vilaró, L, Szafranska, J, Massegur-Solench, H, León-Vintró, X. Surgical treatment of 186 sinonasal inverted papillomas and analysis of the immunohistochemical and molecular features associated with recurrences*. AMERICAN JOURNAL OF OTOLARYNGOLOGY. 2024; 45(2)DOI:10.1016/j.amjoto.2023.104129. PMID:38070378. IF:1.700(Q2/4D).

Lassaletta L, Acle Cervera L, Altuna X, Amilibia Cabeza E, Arístegui Ruiz M, Batuecas Caletrio Á, Benítez Del Rosario J, Cabanillas Farpón R, Costales Marcos M, Escada P, Espinosa-Sánchez JM, García Leal R, Gavilán J, Gómez Martínez J, González-Aguado R, Martinez-Glez V, Guerra Jiménez G, Harguindey Antolí-Candela A, Hernández García BJ, Orús Dotú C, Polo López R, Manrique M, Martín Sanz E, Martínez Álvarez R, Martínez H, Martínez-Martínez M, Rey-Martinez J, Ropero Romero F, Santa Cruz Ruiz S, Vallejo LÁ, Soto Varela A, Varela-Nieto I, Morales Puebla JM. Clinical practice guideline on the management of vestibular schwannoma.. Acta Otorrinolaringologica Espanola. 2024; 75(2)DOI:10.1016/j.otoeng.2023.10.005. PMID:38346489. IF:(Q/D).

Moreno-Luna R, Mariño Sánchez F, Kaen A, Gras Cabrerizo JR, Mata Castro N, González García J, Villacampa Aubá JM, Cárdenas Ruiz-Valdepeñas E, Monjas Cánovas I, Del Cuvillo Bernal A, García Piñero A, Maza Solano JM, Fernández de Liesa R, Sánchez-Gómez S, Alobid I. Usefulness of endonasal flaps and grafts in skull base surgery. Consensus document.. Acta Otorrinolaringologica Espanola. 2022; 73(5)DOI:10.1016/j.otoeng.2021.02.004. PMID:36031110. IF:(Q/D).

Zozaya, N, Villaseca, J, Abdalla, F, Calleja, MA, Diez-Martin, JL, Estevez, J, Garcia-Sanz, R, Martinez-Lopez, J, Sierra, J, Vera, R, Hidalgo-Vega, A. A strategic reflection for the management and implementation of CAR-T therapy in Spain: an expert consensus paper. Clinical & Translational Oncology. 2022; 24(6)DOI:10.1007/s12094-021-02757-9. PMID:34997475. IF:3.400(Q3/6D).

Burger, JA, Robak, T, Demirkan, F, Bairey, O, Moreno, C, Simpson, D, Munir, T, Stevens, DA, Dai, S, Cheung, LWK, Kwei, K, Lal, I, Hsu, EM, Kipps, TJ, Tedeschi, A. Up to 6.5 years (median 4 years) of follow-up of first-line ibrutinib in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma and high-risk genomic features: integrated analysis of two phase 3 studies. LEUKEMIA & LYMPHOMA. 2022; 63(6)DOI:10.1080/10428194.2021.2020779. PMID:35014928. IF:2.600(Q3/7D).

Halwani, AS, Panizo, C, Isufi, I, Herrera, AF, Okada, CY, Cull, EH, Kis, B, Chaves, JM, Bartlett, NL, Ai, WY, De La Cruz-Merino, L, Bryan, LJ, Houot, R, Linton, K, Briones, J, Chau, I, von Keudell, GR, Lu, HL, Yakovich, A, Chen, M, Ter Meulen, JH, Yurasov, S, Hsu, FJ, Flowers, CR. Phase 1/2 study of intratumoral G100 (TLR4 agonist) with or without pembrolizumab in follicular lymphoma. LEUKEMIA & LYMPHOMA. 2022; 63(4)DOI:10.1080/10428194.2021.2010057. PMID:34865586. IF:2.600(Q3/7D).

Hernandez-Boluda, JC, Pereira, A, Zinger, N, Gras, L, Martino, R, Paneesha, S, Finke, J, Chinea, A, Rambaldi, A, Robin, M, Saccardi, R, Natale, A, Snowden, JA, Tsirigotis, P, Vallejo, C, Wulf, G, Xicoy, B, Russo, D, Maertens, J, Daguindau, E, Lenhoff, S, Hayden, P, Czerw, T, McLornan, DP, Yakoub-Agha, I. Allogeneic hematopoietic cell transplantation in patients with myeloid/lymphoid neoplasm with FGFR1-rearrangement: a study of the Chronic Malignancies Working Party of EBMT. BONE MARROW TRANSPLANTATION. 2022; 57(3)DOI:10.1038/s41409-021-01553-x. PMID:35066569. IF:4.800(Q1/2D).

Pinana, JL, Vazquez, L, Martino, R, de la Camara, R, Sureda, A, Rodriguez-Veiga, R, Garrido, A, Sierra, J, Ribera, JM, Torrent, A, Mateos, MV, de la Rubia, J, Tormo, M, Diez-Campelo, M, Garcia-Gutierrez, V, Alvarez-Larran, A, Sancho, JM, MartinGarcia-Sancho, A, Yanez, L, Simon, JAP, Barba, P, Abrisqueta, P, Alvarez-Twose, I, Bonanad, S, Lecumberri, R, Ruiz-Camps, I, Navarro, D, Hernandez-Rivas, JA, Cedillo, A, Garcia-Sanz, R, Bosch, F. Spanish Society of Hematology and Hemotherapy expert consensus opinion for SARS-CoV-2 vaccination in onco-hematological patients. LEUKEMIA & LYMPHOMA. 2022; 63(3)DOI:10.1080/10428194.2021.1992619. PMID:34668835. IF:2.600(Q3/7D).

Martino, R, Garcia-Cadenas, I, Esquirol, A. Daratumumab may be the most effective treatment for post-engraftment pure red cell aplasia due to persistent anti-donor isohemagglutinins after major ABO-mismatched allogeneic transplantation. BONE MARROW TRANSPLANTATION. 2022; 57(2)DOI:10.1038/s41409-021-01507-3. PMID:34711914. IF:4.800(Q1/2D).

Dlouhy, I, Karube, K, Enjuanes, A, Salaverria, I, Nadeu, F, Ramis-Zaldivar, JE, Valero, JG, Rivas-Delgado, A, Magnano, L, Martin-Garcia, D, Perez-Galan, P, Clot, G, Rovira, J, Jares, P, Balague, O, Gine, E, Mozas, P, Briones, J, Sancho, JM, Salar, A, Mercadal, S, Alcoceba, M, Valera, A, Campo, E, Lopez-Guillermo, A. Revised International Prognostic Index and genetic alterations are associated with early failure to R-CHOP in patients with diffuse large B-cell lymphoma. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(3)DOI:10.1111/bjh.17858. PMID:34632572. IF:6.500(Q1/3D).

Ribera, J, Granada, I, Morgades, M, Gonzalez, T, Ciudad, J, Such, E, Calasanz, MJ, Mercadal, S, Coll, R, Gonzalez-Campos, J, Tormo, M, Garcia-Cadenas, I, Gil, C, Cervera, M, Barba, P, Costa, D, Ayala, R, Bermudez, A, Orfao, A, Ribera, JM. Prognostic heterogeneity of adult B-cell precursor acute lymphoblastic leukaemia patients with t(1;19)(q23;p13)/ TCF3-PBX1 treated with measurable residual disease-oriented protocols. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(3)DOI:10.1111/bjh.17844. PMID:34549416. IF:6.500(Q1/3D).

Allan, JN, Shanafelt, T, Wiestner, A, Moreno, C, O'Brien, SM, Li, JL, Krigsfeld, G, Dean, JP, Ahn, IE. Long-term efficacy of first-line ibrutinib treatment for chronic lymphocytic leukaemia in patients with TP53 aberrations: a pooled analysis from four clinical trials. BRITISH JOURNAL OF HAEMATOLOGY. 2022; 196(4)DOI:10.1111/bjh.17984. PMID:34865212. IF:6.500(Q1/3D).